Efficacy and Safety of Ribavirin plus High Dose Interferonα-2b for Treatment of Patients with Chronic Hepatitis C Who Relapsed After Previous Interferon-α Therapy
碩士 === 國立成功大學 === 臨床藥學研究所 === 89 === Background：The hepatitis C is a major health care problem worldwide. Approximately 85﹪of patients with acute hepatitis C virus( HCV ) infection develop chronic hepatitis and 20-30﹪of these patients will progress to cirrhosis within 10-20 years after infection. Th...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2001
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/30770063425393639237 |